Literature DB >> 15292296

Functional deletion of the calcium-sensing receptor in a case of neonatal severe hyperparathyroidism.

Bryan K Ward1, Aaron L Magno, Elizabeth A Davis, Aylin C Hanyaloglu, Bronwyn G A Stuckey, Mark Burrows, Karin A Eidne, Adrian K Charles, Thomas Ratajczak.   

Abstract

Heterozygous inactivating mutations of the calcium-sensing receptor (CaR) cause familial hypocalciuric hypercalcemia, whereas homozygous or compound heterozygous inactivating mutations normally cause neonatal severe hyperparathyroidism. In a case of neonatal severe hyperparathyroidism characterized by moderately severe hypercalcemia and very high PTH levels, coupled with evidence of hyperparathyroidism and effects on brain development not previously demonstrated, we detected point mutations on separate alleles of the CaR, resulting in premature stop codon substitutions at G94 and R648. This led to severely truncated receptors and an effective so-called knockout of functional CaR. FLAG-tagged, truncated receptors were expressed in HEK293 cells for functional analysis. Confocal microscopy demonstrated cytoplasmic localization of the G94stop receptor, whereas the R648stop receptor was present both in the cytoplasm and associated with the cell membrane. Only the R648stop receptor could be detected by Western analysis. Functional assays in which R648stop and wild-type receptor were cotransfected into HEK293 cells demonstrated a reduction in wild-type Ca(2+)-responsiveness by the R648stop receptor, even at physiological Ca(2+) levels, thus simulating familial hypocalciuric hypercalcemia in relatives of the infant who were heterozygous for the R648stop mutation. The R648stop receptor alone was nonresponsive to Ca(2+). This case contributes to our understanding of the clinical manifestation of a CaR knockout.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15292296     DOI: 10.1210/jc.2003-031653

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

1.  Neonatal severe hyperparathyroidism: further clinical and molecular delineation.

Authors:  Fawziya A Al-Khalaf; Adel Ismail; Ashraf T Soliman; David E C Cole; Tawfeg Ben-Omran
Journal:  Eur J Pediatr       Date:  2010-10-23       Impact factor: 3.183

2.  Neonatal severe hyperparathyroidism due to compound heterozygous mutation of calcium sensing receptor (CaSR) gene presenting as encephalopathy.

Authors:  Abhishek Kulkarni; Mahesh Mohite; Ramaa Vijaykumar; Prasanna Bansode; Sachin Murade; Parag M Tamhankar
Journal:  Indian J Pediatr       Date:  2014-04-26       Impact factor: 1.967

3.  Association of common variants in the calcium-sensing receptor gene with serum calcium levels in East Asians.

Authors:  Nadimuthu Vinayagamoorthy; Seon-Hee Yim; Seung-Hyun Jung; Sung-Won Park; Young Jin Kim; Bong-Jo Kim; Yeun-Jun Chung
Journal:  J Hum Genet       Date:  2015-05-14       Impact factor: 3.172

Review 4.  The Calcium-Sensing Receptor and the Parathyroid: Past, Present, Future.

Authors:  Arthur D Conigrave
Journal:  Front Physiol       Date:  2016-12-15       Impact factor: 4.566

5.  Identification of a novel large CASR deletion in a patient with familial hypocalciuric hypercalcemia.

Authors:  Alejandro García-Castaño; Leire Madariaga; Sharona Azriel; Gustavo Pérez de Nanclares; Idoia Martínez de LaPiscina; Rosa Martínez; Inés Urrutia; Aníbal Aguayo; Sonia Gaztambide; Luis Castaño
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2018-12-05

6.  Osteoclast-Released Wnt-10b Underlies Cinacalcet Related Bone Improvement in Chronic Kidney Disease.

Authors:  Cai-Mei Zheng; Yung-Ho Hsu; Chia-Chao Wu; Chien-Lin Lu; Wen-Chih Liu; Jing-Quan Zheng; Yuh-Feng Lin; Hui-Wen Chiu; Tian-Jong Chang; Jia-Fwu Shyu; Kuo-Cheng Lu
Journal:  Int J Mol Sci       Date:  2019-06-08       Impact factor: 5.923

7.  Homer1 mediates CaSR-dependent activation of mTOR complex 2 and initiates a novel pathway for AKT-dependent β-catenin stabilization in osteoblasts.

Authors:  Mark S Rybchyn; Kazi S Islam; Tara C Brennan-Speranza; Zhiqiang Cheng; Sarah C Brennan; Wenhan Chang; Rebecca S Mason; Arthur David Conigrave
Journal:  J Biol Chem       Date:  2019-09-16       Impact factor: 5.486

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.